HONG KONG, Feb 22, 2023 – (ACN Newswire) – Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited (“Essex Bio-Investment”) and Zhuhai Essex Bio-Pharmaceutical Co. Ltd (“Zhuhai Essex”), signed an amendment agreement (the “Amendment Agreement”) with Shanghai Henlius Biotech…
Read More
About The Author
